Prime Liquid
NDC Package 55714-2552-1
Package Information
Prime (ginkgo biloba, ruta graveolens, agnus castus, allium sativum, ambra grisea, angelica sinensis radix, aralia quinquefolia, arnica montana, arsenicum album, avena sativa, baptisia tinctoria, baryta carbonica, bryonia, cantharis, lachesis mutus, lycopodium clavatum, nux vomica, phosphoricum acidum, pulsatilla, ruta graveolens, sabal serrulata, selenium metallicum, zincum metallicum.) liquids is formulated for symptoms associated with aging sucha as impared memory,, loss of vitality, general weakness and dry, wrinkled skin. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-2552.
Identification & Billing
Clinical Specifications
- AMBERGRIS 15 [hp_X]/mL
- AMERICAN GINSENG 15 [hp_X]/mL
- ANEMONE PULSATILLA 15 [hp_X]/mL
- ANGELICA SINENSIS ROOT 15 [hp_X]/mL
- ARNICA MONTANA 15 [hp_X]/mL
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP 15 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 15 [hp_X]/mL
- BARIUM CARBONATE 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CHASTE TREE FRUIT 15 [hp_X]/mL
- GARLIC 15 [hp_X]/mL
- GINKGO 6 [hp_X]/mL
- LACHESIS MUTA VENOM 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- LYTTA VESICATORIA 15 [hp_X]/mL
- PHOSPHORIC ACID 15 [hp_X]/mL
- RUTA GRAVEOLENS FLOWERING TOP 15 [hp_X]/mL
- SAW PALMETTO 15 [hp_X]/mL
- SELENIUM 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- ZINC 15 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-2552 - Prime
- 55714-2552-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-2552 - Prime
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-2552-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Prime, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains ambergris; american ginseng; anemone pulsatilla; angelica sinensis root; arnica montana; arsenic trioxide; avena sativa flowering top; baptisia tinctoria root; barium carbonate; bryonia alba root; chaste tree fruit; garlic; ginkgo; lachesis muta venom; lycopodium clavatum spore; lytta vesicatoria; phosphoric acid; ruta graveolens flowering top; saw palmetto; selenium; strychnos nux-vomica seed; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on August 01, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714255201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.